• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对乙酰氨基酚使用对急性呼吸窘迫综合征患者死亡率的影响:基于 MIMIC-IV 数据库的二次数据挖掘。

Effects of acetaminophen use on mortality of patients with acute respiratory distress syndrome: secondary data mining based on the MIMIC-IV database.

机构信息

Anhui Medical University, Hefei, Anhui Province, 230022, China.

Department of Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui Province, 241000, China.

出版信息

BMC Pulm Med. 2024 Nov 14;24(1):568. doi: 10.1186/s12890-024-03379-x.

DOI:10.1186/s12890-024-03379-x
Abstract

BACKGROUND

Acetaminophen is a commonly used analgesic after surgery, and its impact on prognosis in patients with acute respiratory distress syndrome (ARDS) has not been studied. This study explores the association between the use of acetaminophen and the risk of mortality in patients with ARDS.

METHODS

In this retrospective cohort study, 3,227 patients with ARDS who had or had not received acetaminophen were obtained from the Medical Information Mart for Intensive Care IV, patients were divided into acetaminophen and non- acetaminophen groups. In-hospital mortality of ARDS patients was considered as primary end point. We used univariate and multivariate Cox regression analyses to assess the relationship of acetaminophen use and in-hospital mortality in patients with ARDS. Subgroup analysis was performed according to age, gender, and severity of ARDS.

RESULTS

Of the total patients, 2,438 individuals were identified as acetaminophen users. The median duration of follow-up was 10.54 (5.57, 18.82) days. The results showed that the acetaminophen use was associated with a decreased risk of in-hospital mortality [hazard ratio (HR) = 0.67, 95% confidence interval (CI): 0.57-0.78]. Across various subgroups of patients with ARDS based on age, gender, and severity, acetaminophen use exhibited an association with reduced risk of in-hospital mortality.

CONCLUSION

Acetaminophen use was associated with in-hospital mortality of patients with ARDS. Acetaminophen therapy may represent a promising therapeutic option for ARDS patients and warrants further investigation.

摘要

背景

扑热息痛是手术后常用的镇痛药,但其对急性呼吸窘迫综合征(ARDS)患者预后的影响尚未研究。本研究探讨了扑热息痛的使用与 ARDS 患者死亡风险之间的关系。

方法

在这项回顾性队列研究中,我们从医疗信息共享数据库中获取了 3227 名接受或未接受扑热息痛治疗的 ARDS 患者,将患者分为扑热息痛组和非扑热息痛组。将 ARDS 患者的院内死亡率作为主要终点。我们使用单变量和多变量 Cox 回归分析评估 ARDS 患者扑热息痛使用与院内死亡率的关系。根据年龄、性别和 ARDS 严重程度进行亚组分析。

结果

在所有患者中,有 2438 名患者被确定为扑热息痛使用者。中位随访时间为 10.54(5.57,18.82)天。结果表明,扑热息痛的使用与降低院内死亡率相关[风险比(HR)=0.67,95%置信区间(CI):0.57-0.78]。在基于年龄、性别和严重程度的各种 ARDS 患者亚组中,扑热息痛的使用均与降低院内死亡率相关。

结论

扑热息痛的使用与 ARDS 患者的院内死亡率相关。扑热息痛治疗可能是 ARDS 患者有前途的治疗选择,值得进一步研究。

相似文献

1
Effects of acetaminophen use on mortality of patients with acute respiratory distress syndrome: secondary data mining based on the MIMIC-IV database.对乙酰氨基酚使用对急性呼吸窘迫综合征患者死亡率的影响:基于 MIMIC-IV 数据库的二次数据挖掘。
BMC Pulm Med. 2024 Nov 14;24(1):568. doi: 10.1186/s12890-024-03379-x.
2
Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: A cohort study.在 MIMIC-IV 数据库中,ICU 前阿司匹林给药与 ARDS 死亡率之间的关联:一项队列研究。
Pulm Pharmacol Ther. 2024 Jun;85:102288. doi: 10.1016/j.pupt.2024.102288. Epub 2024 Mar 8.
3
Association Between Obesity and Short-And Long-Term Mortality in Patients With Acute Respiratory Distress Syndrome Based on the Berlin Definition.基于柏林定义的肥胖与急性呼吸窘迫综合征患者短期和长期死亡率的相关性研究。
Front Endocrinol (Lausanne). 2021 Feb 12;11:611435. doi: 10.3389/fendo.2020.611435. eCollection 2020.
4
Association between glucocorticoid administration and outcomes in patients with ARDS based on the MIMIC-III database.基于 MIMIC-III 数据库的糖皮质激素给药与 ARDS 患者结局的关系。
Medicine (Baltimore). 2024 Aug 9;103(32):e39239. doi: 10.1097/MD.0000000000039239.
5
Association of coagulation function with the risk of in-hospital mortality in patients with severe acute respiratory distress syndrome.凝血功能与严重急性呼吸窘迫综合征患者住院死亡率的相关性研究。
Am J Med Sci. 2024 Aug;368(2):143-152. doi: 10.1016/j.amjms.2024.04.012. Epub 2024 Apr 16.
6
Association between BUN/creatinine ratio and the risk of in-hospital mortality in patients with trauma-related acute respiratory distress syndrome: a single-centre retrospective cohort from the MIMIC database.BUN/creatinine 比值与创伤相关急性呼吸窘迫综合征患者住院死亡率的关系:来自 MIMIC 数据库的单中心回顾性队列研究。
BMJ Open. 2023 Apr 28;13(4):e069345. doi: 10.1136/bmjopen-2022-069345.
7
Platelet count as a prognostic marker for acute respiratory distress syndrome.血小板计数作为急性呼吸窘迫综合征的预后标志物。
BMC Pulm Med. 2024 Aug 17;24(1):396. doi: 10.1186/s12890-024-03204-5.
8
Extracorporeal support for trauma: A trauma quality improvement project (TQIP) analysis in patients with acute respiratory distress syndrome.创伤体外生命支持:急性呼吸窘迫综合征患者的创伤质量改进项目(TQIP)分析。
Am J Emerg Med. 2021 Oct;48:170-176. doi: 10.1016/j.ajem.2021.04.083. Epub 2021 Apr 30.
9
Prognosis of Acute Respiratory Distress Syndrome in Patients With Hematological Malignancies.血液恶性肿瘤患者急性呼吸窘迫综合征的预后。
J Intensive Care Med. 2020 Apr;35(4):364-370. doi: 10.1177/0885066617753566. Epub 2018 Jan 17.
10
Risk factors for in-hospital mortality in recipients of allogeneic hematopoietic stem cell transplantation with acute respiratory distress syndrome: a retrospective study based on the 2023 new definition of acute respiratory distress syndrome.急性呼吸窘迫综合征行异基因造血干细胞移植受者院内死亡的危险因素:基于 2023 年急性呼吸窘迫综合征新定义的回顾性研究。
BMC Pulm Med. 2024 Aug 13;24(1):391. doi: 10.1186/s12890-024-03195-3.

引用本文的文献

1
Significant adverse prognostic events in patients with urosepsis: a machine learning based model development and validation study.尿脓毒症患者的重大不良预后事件:一项基于机器学习的模型开发与验证研究。
Front Cell Infect Microbiol. 2025 Aug 8;15:1623109. doi: 10.3389/fcimb.2025.1623109. eCollection 2025.
2
Early acetaminophen use is associated with the reduced mortality risk in patients with sepsis-associated encephalopathy: a retrospective study.早期使用对乙酰氨基酚与脓毒症相关性脑病患者死亡风险降低相关:一项回顾性研究。
Eur J Med Res. 2025 Jun 23;30(1):512. doi: 10.1186/s40001-025-02786-y.
3
The J-shaped relationship between serum osmolality and all-cause mortality in critically ill patients with myocardial infarction: a retrospective cohort study.

本文引用的文献

1
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.对脓毒症危重症患者器官功能障碍的预防和治疗用对乙酰氨基酚:ASTER 随机临床试验。
JAMA. 2024 Aug 6;332(5):390-400. doi: 10.1001/jama.2024.8772.
2
Development and validation of the prediction model for mortality in patients with diabetic kidney disease in intensive care unit: a study based on medical information Mart for intensive care.基于重症监护医疗信息集市的重症监护病房糖尿病肾病患者死亡率预测模型的建立与验证研究。
Ren Fail. 2023;45(2):2257808. doi: 10.1080/0886022X.2023.2257808. Epub 2023 Sep 19.
3
心肌梗死重症患者血清渗透压与全因死亡率之间的J形关系:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2025 Mar 21;16:1542403. doi: 10.3389/fendo.2025.1542403. eCollection 2025.
Brief Report: Acetaminophen Reduces Neoadjuvant Chemoimmunotherapy Efficacy in Patients With NSCLC by Promoting Neutrophil Extracellular Trap Formation: Analysis From a Phase 2 Clinical Trial.
简短报告:对乙酰氨基酚通过促进中性粒细胞胞外陷阱形成降低非小细胞肺癌患者新辅助化疗免疫治疗疗效:来自一项2期临床试验的分析
JTO Clin Res Rep. 2023 Jul 27;4(9):100556. doi: 10.1016/j.jtocrr.2023.100556. eCollection 2023 Sep.
4
Early Postoperative Acetaminophen Administration and Severe Acute Kidney Injury After Cardiac Surgery.术后早期应用对乙酰氨基酚与心脏手术后严重急性肾损伤。
Am J Kidney Dis. 2023 Jun;81(6):675-683.e1. doi: 10.1053/j.ajkd.2022.11.009. Epub 2022 Dec 29.
5
Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: A retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases.用于预测心力衰竭合并高血压重症患者28天全因院内死亡率的可解释机器学习:一项基于重症监护医学信息集市数据库-IV和电子重症监护病房数据库的回顾性队列研究
Front Cardiovasc Med. 2022 Oct 12;9:994359. doi: 10.3389/fcvm.2022.994359. eCollection 2022.
6
Apremilast ameliorates acute respiratory distress syndrome by inhibiting neutrophil-induced oxidative stress.阿普米司特通过抑制中性粒细胞诱导的氧化应激改善急性呼吸窘迫综合征。
Biomed J. 2023 Aug;46(4):100560. doi: 10.1016/j.bj.2022.09.001. Epub 2022 Sep 11.
7
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes.急性呼吸窘迫综合征:病因、病理生理学和表型。
Lancet. 2022 Oct 1;400(10358):1145-1156. doi: 10.1016/S0140-6736(22)01485-4. Epub 2022 Sep 4.
8
Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征。
Emerg Med Clin North Am. 2022 Aug;40(3):459-472. doi: 10.1016/j.emc.2022.05.002. Epub 2022 May 10.
9
Prognostic value of glucose-to-lymphocyte ratio in critically ill patients with acute respiratory distress syndrome: A retrospective cohort study.急性呼吸窘迫综合征危重症患者血糖与淋巴细胞比值的预后价值:一项回顾性队列研究。
J Clin Lab Anal. 2022 May;36(5):e24397. doi: 10.1002/jcla.24397. Epub 2022 Mar 31.
10
Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: an updated meta-analysis of randomized clinical trials with trial sequential analysis.糖皮质激素治疗急性呼吸窘迫综合征患者死亡率降低:随机临床试验的更新荟萃分析和试验序贯分析。
Crit Care. 2021 Mar 26;25(1):122. doi: 10.1186/s13054-021-03546-0.